Skip to main navigation

*

Client nav

About Arcturus

RNA Medicines

Technologies

Pipeline

Platforms

Business Development

Publications

Investor Relations

Media Coverage

Categories

Year

Arcturus Therapeutics Nasdaq Tower 2nd Anniversary 1.9 MB

November 16, 2019

How to Invest in MRNA Technology

August 30, 2019

Arcturus Surges Ahead in the mRNA Market, Regaining 100% Rights to OTC Deficien…

February 11, 2019

Arcturus Therapeutics Nasdaq Tower 1st Anniversary 2 MB

November 16, 2018

JLABS Impact Report 2018

October 26, 2018

Arcturus Therapeutics Announces Completion of Merger with Alcobra Ltd. and Comm…

November 16, 2017

Pictures by Ernst and Young (Finalists for the Entrepreneur Of The Year 2017 Aw…

August 23, 2017

Arcturus Therapeutics in the list of Cystic Fibrosis Key Companies

August 9, 2017

Arcturus Therapeutics Inc. is Listed in the Key Players List; Involved in Non A…

July 13, 2017

The Korea Herald News on Arcturus Therapeutics Inc.

July 7, 2017

Pagination

First page
Previous page
Page 1
Page 2
Current page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Next page
Last page

Displaying 21 - 30 of 73

Arcturus-Covid19 Message.jpg

Nasdaq combined

Investor Home

Corporate Governance

Governance Highlights
Management Team
Board of Directors
Committee Composition

Financials & Filings

SEC Filings
Annual Reports
Quarterly Results

News & Events

Press Releases
Videos
Media Coverage
Presentations
Events

Stock Information

Stock Quote
Historical Price Lookup
Analyst Coverage

Investor Resources

Investor FAQ
Contact IR
Email Alerts

Home
Contact
Careers
Legal

© 2021 Arcturus Therapeutics, Inc.

Search